Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...

Jagged-2, a signaling protein, may be a potential therapeutic target for slowing or halting the progression of PAH, according ...

Uptravi may reduce blood pressure in the lungs of children with pulmonary arterial hypertension, according to a meta-analysis ...

Columnist Mike Naple would rather be focusing on baking utensils this holiday season, but living with PH requires multiple ...

Columnist Jen Cueva thought she had the flu, but it turned out to be much more serious. She says that with PH, life often gives you lemons.

Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new study found.

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary ...

The rare and severe lung disease called pulmonary hypertension (PH) affects the pulmonary arteries, causing high blood pressure. The pulmonary arteries transport the blood from the right heart ...

This is Samuele Butera’s story: Alexis. Gerry. Chelsea. Sophia. Dori. These are some of the amazing advocates living with pulmonary arterial hypertension (PAH) whom I’ve been privileged to know in my ...

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...

Yutrepia, an inhaled formulation of treprostinil, was generally well tolerated and improved the quality of life for people with pulmonary arterial hypertension (PAH) in the Phase 3 INSPIRE clinical ...